Prevalence of and Short-term Changes in Conjunctival Manifestations Among Patients With SARS-CoV-2 Infection

Emilio Pedrotti; Erika Bonacci; Marco Ligozzi; Jacopo Bonetto; Raphael Kilian; Davide Gibellini; Giorgio Marchini

doi:10.1001/jamanetworkopen.2022.7734

Prevalence of and Short-term Changes in Conjunctival Manifestations Among Patients With SARS-CoV-2 Infection

JAMA Netw Open. 2022 Apr 1;5(4):e227734. doi: 10.1001/jamanetworkopen.2022.7734.

Authors

Emilio Pedrotti¹, Erika Bonacci¹, Marco Ligozzi², Jacopo Bonetto³, Raphael Kilian¹, Davide Gibellini², Giorgio Marchini¹

Affiliations

¹ Ophthalmic Unit, Department of Neurosciences, Biomedicine, and Movement Sciences, University of Verona, Verona, Italy.
² Microbiology and Virology Section, Department of Diagnostic and Public Health, University of Verona, Verona, Italy.
³ Ophthalmic Unit, Hospital of Meran, Merano, Italy.

Abstract

This cohort study assesses the prevalence of SARS-CoV-2–related conjunctival manifestations and conjunctival swab positivity on hospital admission and 3 days thereafter for patients not receiving anti-inflammatory treatment.

MeSH terms

COVID-19* / epidemiology
Conjunctiva
Humans
Prevalence
RNA, Viral
SARS-CoV-2

Substances

RNA, Viral